Solvent-based or nab-paclitaxel plus ramucirumab for pretreated gastric cancer with peritoneal dissemination and prespecified biomarker analysis (P-SELECT/WJOG10617G): a randomised phase 2 trial in Japan

Kenro Hirata, Yasuo Hamamoto, Hirokazu Shoji, Hiroki Hara, Chihiro Kondoh, Hisateru Yasui, Takeshi Kajiwara, Eishi Baba, Takayuki Ando, Naotoshi Sugimoto, Hisato Kawakami, Hiroo Katsuya, Michitaka Nagase, Yoshiyuki Yamamoto, Kenichi Yoshimura, Masahiko Ando, Chiyo K. Imamura, Kentaro Yamazaki, Shuichi Hironaka, Kei Muro

Open source

DOI: 10.1016/j.eclinm.2026.103768
Published: 2026-02
Container: eClinicalMedicine
Publisher: Elsevier BV
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/j.eclinm.2026.103768,
  title = {Solvent-based or nab-paclitaxel plus ramucirumab for pretreated gastric cancer with peritoneal dissemination and prespecified biomarker analysis (P-SELECT/WJOG10617G): a randomised phase 2 trial in Japan},
  author = {Kenro Hirata and Yasuo Hamamoto and Hirokazu Shoji and Hiroki Hara and Chihiro Kondoh and Hisateru Yasui and Takeshi Kajiwara and Eishi Baba and Takayuki Ando and Naotoshi Sugimoto and Hisato Kawakami and Hiroo Katsuya and Michitaka Nagase and Yoshiyuki Yamamoto and Kenichi Yoshimura and Masahiko Ando and Chiyo K. Imamura and Kentaro Yamazaki and Shuichi Hironaka and Kei Muro},
  year = {2026},
  journal = {eClinicalMedicine},
  doi = {10.1016/j.eclinm.2026.103768},
  url = {https://doi.org/10.1016/j.eclinm.2026.103768}
}

RIS

TY  - JOUR
TI  - Solvent-based or nab-paclitaxel plus ramucirumab for pretreated gastric cancer with peritoneal dissemination and prespecified biomarker analysis (P-SELECT/WJOG10617G): a randomised phase 2 trial in Japan
AU  - Kenro Hirata
AU  - Yasuo Hamamoto
AU  - Hirokazu Shoji
AU  - Hiroki Hara
AU  - Chihiro Kondoh
AU  - Hisateru Yasui
AU  - Takeshi Kajiwara
AU  - Eishi Baba
AU  - Takayuki Ando
AU  - Naotoshi Sugimoto
AU  - Hisato Kawakami
AU  - Hiroo Katsuya
AU  - Michitaka Nagase
AU  - Yoshiyuki Yamamoto
AU  - Kenichi Yoshimura
AU  - Masahiko Ando
AU  - Chiyo K. Imamura
AU  - Kentaro Yamazaki
AU  - Shuichi Hironaka
AU  - Kei Muro
PY  - 2026
JO  - eClinicalMedicine
DO  - 10.1016/j.eclinm.2026.103768
UR  - https://doi.org/10.1016/j.eclinm.2026.103768
ER  -

APA

Hirata, K., Hamamoto, Y., Shoji, H., Hara, H., Kondoh, C., Yasui, H., Kajiwara, T., Baba, E., Ando, T., Sugimoto, N., Kawakami, H., Katsuya, H., Nagase, M., Yamamoto, Y., Yoshimura, K., Ando, M., Imamura, C. K., Yamazaki, K., Hironaka, S., & Muro, K. (2026). Solvent-based or nab-paclitaxel plus ramucirumab for pretreated gastric cancer with peritoneal dissemination and prespecified biomarker analysis (P-SELECT/WJOG10617G): a randomised phase 2 trial in Japan. eClinicalMedicine. https://doi.org/10.1016/j.eclinm.2026.103768

Source records

crossref · retrieved 2026-09-26T00:51:09.963Z